Cargando…
Decrypting the potency of anti-cancer therapeutics by using mass spectrometry to quantify post-translational modifications
In a recent issue of Science, Zecha et al.(1) present decryptM, an approach aimed at defining the mechanisms of action of anti-cancer therapeutics through systems-level analysis of protein post-translational modifications (PTMs). By using a broad range of concentrations, decryptM generates drug resp...
Autores principales: | Herbst, Sophie A., White, Forest M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261922/ https://www.ncbi.nlm.nih.gov/pubmed/37323574 http://dx.doi.org/10.1016/j.crmeth.2023.100483 |
Ejemplares similares
-
Mitochondrial translation, dynamics, and lysosomes combine to extend lifespan
por: Ali, Levi, et al.
Publicado: (2020) -
Patient collaboration in COVID-19 research: translating ideas to reality
por: Kirby, Tony
Publicado: (2023) -
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
por: Azevedo, Rita, et al.
Publicado: (2022) -
Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting
por: Chien, A. Jo, et al.
Publicado: (2022) -
Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry
por: Olsen, Jesper V., et al.
Publicado: (2013)